Mark Smales

By Admin

MS is an academic at the University of Kent and a Principal Investigator at NIBRT in Dublin, Ireland under a joint appointment partnership with the University of Kent. He has been active in research in the wider bioprocessing area for >25 years with the work having a focus on improving: (a) biotherapeutic recombinant protein yields and quality, including design and manufacture of novel format biotherapeutics that are difficult to express, (b) the manufacture of gene therapies, (c) the process of re-tuning cell processes and metabolism via synthetic biology approaches, (d) the design, manufacturability and testing of RNA therapies, (e) extracellular vesicle production and application, (f) development of diagnostics.